Enhancement of Stroke Rehabilitation With Levodopa
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg compared to placebo
(given in addition to standardized rehabilitation based on the principles of motor learning)
and whether there is an association with a patient-relevant enhancement of functional
recovery in acute stroke patients. Study participants will be randomized 1:1.